Three-quarters of the world has no idea what its omega-3 levels are
A sweeping review of global omega-3 data, drawing on nearly a quarter-million blood samples across 48 countries, has revealed that most of humanity lives in a kind of nutritional blind spot — unmeasured, under-nourished in a critical fatty acid, and largely unaware of the cardiovascular risk that follows. The Omega-3 Index, a simple metric linking red blood cell chemistry to heart health, paints a world where modest progress in wealthy nations masks a vast, uncharted deficiency elsewhere. What science cannot see, it cannot heal — and for billions of people, the map remains blank.
- Blood omega-3 levels in countries like Egypt, Iran, Brazil, and India fall dangerously below the threshold linked to cardiovascular safety, yet these populations have no screening programs and no interventions in place.
- Three-quarters of the world's nations have zero population-level omega-3 data, meaning the true scale of deficiency — and its toll in preventable deaths — is almost certainly far worse than the numbers suggest.
- The research itself is skewed: 92 percent of existing data originates from Europe and North America, leaving Africa, Southeast Asia, the Middle East, and much of South America scientifically invisible on this critical health metric.
- A handful of wealthier nations — the U.S., France, Finland, Iceland — have shown measurable improvement, proving that awareness and dietary change can work, but only where resources and access make them possible.
- Researchers are calling on national health agencies worldwide to begin omega-3 screening and launch dietary or supplementation interventions before the burden of chronic cardiovascular disease deepens further in the world's most vulnerable regions.
A team of researchers has updated the world's most comprehensive map of omega-3 fatty acid levels, and what they found is as much about absence as it is about data. Compiled from 328 studies conducted between 1999 and 2023 — representing blood samples from over 340,000 people across 48 countries — the review reveals a global population largely deficient in EPA and DHA, the omega-3 compounds found in fish and marine sources that the human body cannot produce on its own.
The Omega-3 Index, first proposed in 2004, measures these fatty acids as a percentage of total red blood cell lipids. Above 8 percent is considered healthy; below 4 percent signals high cardiovascular risk. When researchers first mapped the world by this measure in 2016, the gaps were striking. Eight years later, they remain nearly as wide. Seventy-five percent of the world's countries have no population-level omega-3 data at all, and 92 percent of existing measurements come from Europe and North America.
Where numbers do exist, they are alarming. Egypt registered 2.1 percent. Iran, 2.41. Brazil and Guatemala hovered around 3.4. India reached only 3.63. Even several prosperous European nations fell short of the healthy threshold. The brighter findings came from countries where public awareness and dietary access have improved — the United States, France, Finland, and Iceland among them — demonstrating that change is possible, but only where the conditions for it exist.
The deeper concern is what remains unseen. Millions of people in under-resourced regions, with limited access to seafood or supplements and no healthcare infrastructure for nutritional screening, are living with deficiency that goes untracked and unaddressed. The researchers urge national health agencies to begin measuring their populations' omega-3 status and to act on what they find — because a map with this many blank spaces is not just a scientific problem. It is a public health emergency hiding in plain sight.
Researchers updating a global map of omega-3 fatty acid levels have uncovered a troubling picture: most of the world's population lives in countries where their blood omega-3status remains unmeasured, and where measurements do exist, the numbers are dangerously low. The study, published in Progress in Lipid Research, compiled data from 328 studies spanning 1999 to 2023, drawing on blood samples from 342,864 people across 48 countries. What emerged was a portrait of a world divided—some regions showing modest improvement, vast swaths showing critical deficiency, and the majority simply invisible to science.
Omega-3 fatty acids, particularly the compounds EPA and DHA found in fish and marine sources, are nutrients the human body cannot manufacture on its own. They must come from diet. The evidence linking adequate omega-3 levels to reduced risk of heart disease, stroke, early death, and even improved brain function in aging adults has accumulated steadily over two decades. In 2004, researchers proposed a simple metric: the Omega-3 Index, measured as a percentage of total fatty acids in red blood cells. An index above 8 percent was deemed healthy. Below 4 percent meant high cardiovascular risk. The first global map, published in 2016, attempted to color-code the world by this measure. Now, eight years later, researchers have updated that map—and the gaps have barely narrowed.
Of 666 studies initially identified, only 328 met rigorous inclusion criteria. More striking than the number included was the origin of the data: 92 percent came from people in Europe and North America. Africa, most of South America, Southeast Asia, the Middle East, and large portions of Eastern Europe remain essentially unmapped. Three-quarters of the world's countries have no population-level data on omega-3 status whatsoever. Some countries that appeared on the 2016 map—Chile, Tanzania, Kenya, Papua New Guinea, parts of Russia—have dropped off entirely, their data too sparse or outdated to include.
Where data does exist, the picture is grim. Egypt measured at 2.1 percent. Iran at 2.41 percent. The Palestinian Territories at 2.56 percent. Brazil and Guatemala both hovered around 3.4 percent. India at 3.63 percent. All far below the healthy threshold. Even wealthy nations showed concerning levels: Austria, the Netherlands, and Ireland all fell short. The good news, such as it is, came from a handful of countries that have moved in the right direction. The United States, Canada, Italy, Turkey, the United Kingdom, Ireland, and Greece shifted from the red zone into orange. France, Spain, and New Zealand climbed from orange to yellow. Finland and Iceland reached green. These improvements suggest that public awareness and dietary changes can move the needle—but only in places where such awareness exists and dietary options are available.
The researchers note that low seafood consumption is estimated to be the fourth leading dietary factor driving cardiovascular deaths in the United States alone. The relationship almost certainly holds globally, yet most of the world has never been measured. The implication is stark: millions of people in developing nations, in regions with limited healthcare infrastructure and limited access to fish or supplements, are living with omega-3 deficiency that no one is tracking and no one is addressing. They have no baseline, no intervention, no pathway to improvement.
The authors call for urgent action on two fronts: national health agencies must begin screening their populations' omega-3 status, and based on those findings, must implement interventions—dietary education, supplementation programs, or both. Without such efforts, the map will remain incomplete, and the burden of preventable cardiovascular disease will continue to fall heaviest on those least equipped to measure or manage it.
Notable Quotes
Most countries still have virtually no population data on omega-3 status. Most of Africa, Central and South America, Southeast Asia, the Middle East and many countries in Eastern Europe do not yet have reported data on blood fatty acid levels.— Study authors, Progress in Lipid Research
National health agencies around the world should make efforts to assess the omega-3 status of their populations, and based on those data, strive to improve levels in order to reduce risk for many of the chronic diseases plaguing the modern world.— Study authors
The Hearth Conversation Another angle on the story
Why does it matter that we don't have data on three-quarters of the world's countries?
Because you can't fix what you don't measure. If a country has no idea what its population's omega-3 levels are, there's no baseline, no way to know if a problem exists, and no way to know if an intervention works.
But surely the researchers can infer something from neighboring countries or similar populations?
That's the trap. You might assume a developing nation with limited seafood access has low omega-3 levels—and you'd probably be right—but you'd be guessing. And guessing doesn't drive policy or resource allocation. Health agencies need their own data.
The countries with the worst numbers—Egypt, Iran, Brazil—what do they have in common?
Limited access to marine sources of omega-3, mostly. But also, they're not wealthy enough to have robust nutritional surveillance systems. The countries with the best data and the best levels tend to be wealthy, with strong healthcare infrastructure and fish-eating traditions or supplement markets.
So this is partly a measurement problem and partly a real health problem?
Exactly. The measurement problem masks the real health problem. We know low omega-3 is linked to heart disease. We know it's the fourth biggest dietary risk factor for cardiovascular death in America. But in most of the world, we're not even looking.
What would it take to change this?
National governments would need to fund blood screening programs, which costs money they often don't have. Then they'd need to act on the results—educating people about fish, subsidizing supplements, or both. It's not complicated, but it requires will and resources concentrated in places that typically have neither.
Is there any sign that's happening?
Some countries have improved their levels since 2016. But the data gaps haven't closed. We're still flying blind over most of the world.